Brian R. Stanton

Array ( [id] => 3682787 [patent_doc_number] => 05643551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Small animal metastasis model' [patent_app_type] => 1 [patent_app_number] => 8/329679 [patent_app_country] => US [patent_app_date] => 1994-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7627 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643551.pdf [firstpage_image] =>[orig_patent_app_number] => 329679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890041 [patent_doc_number] => 05777193 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Animals with targeted gene disruption' [patent_app_type] => 1 [patent_app_number] => 8/211651 [patent_app_country] => US [patent_app_date] => 1994-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 14461 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777193.pdf [firstpage_image] =>[orig_patent_app_number] => 211651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646771 [patent_doc_number] => 05683906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Preparation of immortalized cells' [patent_app_type] => 1 [patent_app_number] => 8/303983 [patent_app_country] => US [patent_app_date] => 1994-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7772 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683906.pdf [firstpage_image] =>[orig_patent_app_number] => 303983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931127 [patent_doc_number] => 05877396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Mice mutant for functional Fc receptors and method of treating autoimmune diseases' [patent_app_type] => 1 [patent_app_number] => 8/292569 [patent_app_country] => US [patent_app_date] => 1994-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 112 [patent_no_of_words] => 33119 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877396.pdf [firstpage_image] =>[orig_patent_app_number] => 292569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831539 [patent_doc_number] => 05712156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Enhanced implantation, development and maintenance of embryos using leukaemia inhibitory factor' [patent_app_type] => 1 [patent_app_number] => 8/292101 [patent_app_country] => US [patent_app_date] => 1994-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712156.pdf [firstpage_image] =>[orig_patent_app_number] => 292101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3632060 [patent_doc_number] => 05610036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Mutant AOX2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism' [patent_app_type] => 1 [patent_app_number] => 8/288899 [patent_app_country] => US [patent_app_date] => 1994-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 8621 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610036.pdf [firstpage_image] =>[orig_patent_app_number] => 288899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3632328 [patent_doc_number] => 05610053 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells' [patent_app_type] => 1 [patent_app_number] => 8/283125 [patent_app_country] => US [patent_app_date] => 1994-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 18263 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610053.pdf [firstpage_image] =>[orig_patent_app_number] => 283125 [rel_patent_id] =>[rel_patent_doc_number] =>)